Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

En Errata.

Cohen SL, Schneider R, Carrino J, Zeldin R, Pavlov H.

Pain Physician. 2019 Sep;22(5):519. No abstract available.

2.

Radiation Dose Practice Audit of 6,234 Fluoroscopically-Guided Spinal Injections.

Cohen SL, Schneider R, Carrino J, Zeldin R, Pavlov H.

Pain Physician. 2019 Mar;22(2):E119-E125.

3.

Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.

Scully M, Cataland SR, Peyvandi F, Coppo P, Knöbl P, Kremer Hovinga JA, Metjian A, de la Rubia J, Pavenski K, Callewaert F, Biswas D, De Winter H, Zeldin RK; HERCULES Investigators.

N Engl J Med. 2019 Jan 24;380(4):335-346. doi: 10.1056/NEJMoa1806311. Epub 2019 Jan 9.

4.

Tracking Cumulative Radiation Exposure in Orthopaedic Surgeons and Residents: What Dose Are We Getting?

Gausden EB, Christ AB, Zeldin R, Lane JM, McCarthy MM.

J Bone Joint Surg Am. 2017 Aug 2;99(15):1324-1329. doi: 10.2106/JBJS.16.01557.

PMID:
28763418
5.

Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura.

Peyvandi F, Scully M, Kremer Hovinga JA, Knöbl P, Cataland S, De Beuf K, Callewaert F, De Winter H, Zeldin RK.

J Thromb Haemost. 2017 Jul;15(7):1448-1452. doi: 10.1111/jth.13716. Epub 2017 Jun 5.

6.

Efficacy and safety of sublingual tablets of house dust mite allergen extracts: Results of a dose-ranging study in an environmental exposure chamber.

Roux M, Devillier P, Yang WH, Montagut A, Abiteboul K, Viatte A, Zeldin RK.

J Allergy Clin Immunol. 2016 Aug;138(2):451-458.e5. doi: 10.1016/j.jaci.2016.03.039. Epub 2016 May 6.

PMID:
27289490
7.

Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cells.

Mascarell L, Rak S, Worm M, Melac M, Soulie S, Lescaille G, Lemoine F, Jospin F, Paul S, Caplier L, Hasséus B, Björhn C, Zeldin RK, Baron-Bodo V, Moingeon P.

Allergy. 2015 Apr;70(4):408-19. doi: 10.1111/all.12576.

PMID:
25631199
8.

Reply: To PMID 24388010.

Bergmann KC, Demoly P, Abiteboul K, Zeldin RK.

J Allergy Clin Immunol. 2015 Jan;135(1):288-9. doi: 10.1016/j.jaci.2014.09.021. Epub 2014 Oct 28. No abstract available.

PMID:
25441297
9.

Systematic review of guidelines for the management of suspected lung cancer in primary care.

Del Giudice ME, Young SM, Vella ET, Ash M, Bansal P, Robinson A, Skrastins R, Ung Y, Zeldin R, Levitt C.

Can Fam Physician. 2014 Aug;60(8):e395-404. Review.

10.

Guideline for referral of patients with suspected lung cancer by family physicians and other primary care providers.

Del Giudice ME, Young SM, Vella ET, Ash M, Bansal P, Robinson A, Skrastins R, Ung Y, Zeldin R, Levitt C.

Can Fam Physician. 2014 Aug;60(8):711-6, e376-82. Review. English, French.

11.
12.

Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.

Bergmann KC, Demoly P, Worm M, Fokkens WJ, Carrillo T, Tabar AI, Nguyen H, Montagut A, Zeldin RK.

J Allergy Clin Immunol. 2014 Jun;133(6):1608-14.e6. doi: 10.1016/j.jaci.2013.11.012. Epub 2013 Dec 31.

PMID:
24388010
13.

Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy.

Baron-Bodo V, Horiot S, Lautrette A, Chabre H, Drucbert AS, Danzé PM, Sénéchal H, Peltre G, Galvain S, Zeldin RK, Horak F, Moingeon P.

Clin Exp Allergy. 2013 Dec;43(12):1362-73. doi: 10.1111/cea.12187.

PMID:
24261946
14.

Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis.

Didier A, Malling HJ, Worm M, Horak F, Sussman G, Melac M, Soulié S, Zeldin RK.

Clin Exp Allergy. 2013 May;43(5):568-77. doi: 10.1111/cea.12100.

PMID:
23600548
15.

2013 Young Investigator Award winner: how safe is lateral lumbar interbody fusion for the surgeon? A prospective in vivo radiation exposure study.

Taher F, Hughes AP, Sama AA, Zeldin R, Schneider R, Holodny EI, Lebl DR, Fantini GA, Nguyen J, Cammisa FP, Girardi FP.

Spine (Phila Pa 1976). 2013 Jul 15;38(16):1386-92. doi: 10.1097/BRS.0b013e31828705ad.

PMID:
23324926
16.

Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.

Cox LS, Casale TB, Nayak AS, Bernstein DI, Creticos PS, Ambroisine L, Melac M, Zeldin RK.

J Allergy Clin Immunol. 2012 Dec;130(6):1327-34.e1. doi: 10.1016/j.jaci.2012.08.032. Epub 2012 Oct 31.

PMID:
23122534
17.

Synthesis of flinderoles B and C by a gold-catalyzed allene hydroarylation().

Zeldin RM, Toste FD.

Chem Sci. 2011 Sep;2(9):1706-1709. Epub 2011 Jun 24.

18.

Automated telecommunication to obtain longitudinal follow-up in a multicenter cross-sectional COPD study.

Stewart JI, Moyle S, Criner GJ, Wilson C, Tanner R, Bowler RP, Crapo JD, Zeldin RK, Make BJ, Regan EA, For The Copdgene Investigators.

COPD. 2012 Aug;9(5):466-72. doi: 10.3109/15412555.2012.690010. Epub 2012 Jun 7.

19.

Low-frequency jet ventilation through a bronchial blocker for tracheal repair after a rare complication of percutaneous dilatational tracheostomy.

Luyet C, Boudah R, McCartney CJ, Zeldin R, Rizoli S.

J Cardiothorac Vasc Anesth. 2013 Feb;27(1):108-10. doi: 10.1053/j.jvca.2011.04.009. Epub 2011 Jun 30. No abstract available.

PMID:
21723145
20.

Effectiveness of omalizumab in reducing corticosteroid burden in patients with moderate to severe persistent allergic asthma.

Karpel J, Massanari M, Geba GP, Kianifard F, Inhaber N, Zeldin RK.

Ann Allergy Asthma Immunol. 2010 Dec;105(6):465-70. doi: 10.1016/j.anai.2010.09.011.

PMID:
21130385
21.

Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients.

Vogelmeier C, Verkindre C, Cheung D, Galdiz JB, Güçlü SZ, Spangenthal S, Overend T, Henley M, Mizutani G, Zeldin RK.

Pulm Pharmacol Ther. 2010 Oct;23(5):438-44. doi: 10.1016/j.pupt.2010.04.005. Epub 2010 Apr 21.

PMID:
20416390
22.

Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma.

Massanari M, Nelson H, Casale T, Busse W, Kianifard F, Geba GP, Zeldin RK.

J Allergy Clin Immunol. 2010 Feb;125(2):383-9. doi: 10.1016/j.jaci.2009.11.022.

PMID:
20159249
23.

Effect of omalizumab on peripheral blood eosinophilia in allergic asthma.

Massanari M, Holgate ST, Busse WW, Jimenez P, Kianifard F, Zeldin R.

Respir Med. 2010 Feb;104(2):188-96. doi: 10.1016/j.rmed.2009.09.011. Epub 2009 Oct 20.

24.

Adding omalizumab to the therapy of adolescents with persistent uncontrolled moderate--severe allergic asthma.

Massanari M, Milgrom H, Pollard S, Maykut RJ, Kianifard F, Fowler-Taylor A, Geba GP, Zeldin RK.

Clin Pediatr (Phila). 2009 Oct;48(8):859-65. doi: 10.1177/0009922809339054. Epub 2009 Jun 29.

PMID:
19564449
25.

Efficacy of omalizumab in cat-allergic patients with moderate-to-severe persistent asthma.

Massanari M, Kianifard F, Zeldin RK, Geba GP.

Allergy Asthma Proc. 2009 Sep-Oct;30(5):534-9. doi: 10.2500/aap.2009.30.3245. Epub 2009 May 22.

PMID:
19467177
26.

Ligand-controlled access to [4 + 2] and [4 + 3] cycloadditions in gold-catalyzed reactions of allene-dienes.

Mauleón P, Zeldin RM, González AZ, Toste FD.

J Am Chem Soc. 2009 May 13;131(18):6348-9. doi: 10.1021/ja901649s.

27.

Treatment of chronic autoimmune urticaria with omalizumab.

Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK.

J Allergy Clin Immunol. 2008 Sep;122(3):569-73. doi: 10.1016/j.jaci.2008.07.006.

PMID:
18774392
28.

Hyperhidrosis: what is it and why does it occur?

Shargall Y, Spratt E, Zeldin RA.

Thorac Surg Clin. 2008 May;18(2):125-32, v. doi: 10.1016/j.thorsurg.2008.01.001. Review.

PMID:
18557586
29.

Integrating regional and community lung cancer services to improve patient care.

Dahele M, Ung Y, Meharchand J, Shulman H, Zeldin R, Behzadi A, Simone C, Cheng S, Weigensberg C, Sivjee K.

Curr Oncol. 2007 Dec;14(6):234-7.

30.

Time to treat: a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis.

Lo DS, Zeldin RA, Skrastins R, Fraser IM, Newman H, Monavvari A, Ung YC, Joseph H, Downton T, Maxwell L, Meharchand J.

J Thorac Oncol. 2007 Nov;2(11):1001-6.

31.

Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.

Busse WW, Casale TB, Dykewicz MS, Meltzer EO, Bird SR, Hustad CM, Grant E, Zeldin RK, Edelman JM.

Ann Allergy Asthma Immunol. 2006 Jan;96(1):60-8.

PMID:
16440534
32.

Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients.

Zeldin RK, Petruschke RA.

J Antimicrob Chemother. 2004 Jan;53(1):4-9. Epub 2003 Dec 4. Review.

PMID:
14657084
33.

Open-label study of a twice-daily indinavir 800-mg/ritonavir 200-mg regimen in HIV-infected adults failing a protease inhibitor regimen.

Katner HP, Paar DP, Nadler JP, Jensen EH, Wilson HM, Finn TS, Petruschke RA, Zeldin RK.

J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):483-7.

PMID:
12473836
34.

Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults.

Young B, Fischl MA, Wilson HM, Finn TS, Jensen EH, DiNubile MJ, Zeldin RK.

J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):478-82.

PMID:
12473835
36.

The effect of a losartan-based treatment regimen on isolated systolic hypertension.

Cushman WC, Brady WE, Gazdick LP, Zeldin RK.

J Clin Hypertens (Greenwich). 2002 Mar-Apr;4(2):101-7.

37.
38.

Heparinized saline versus normal saline in maintaining patency of the radial artery catheter.

Kulkarni M, Elsner C, Ouellet D, Zeldin R.

Can J Surg. 1994 Feb;37(1):37-42.

PMID:
8306218
39.

Rats acquire spatial learning sets.

Zeldin RK, Olton DS.

J Exp Psychol Anim Behav Process. 1986 Oct;12(4):412-9.

PMID:
3772305
40.

Carcinoma of the extrahepatic bile ducts: results of an aggressive surgical approach.

Langer JC, Langer B, Taylor BR, Zeldin R, Cummings B.

Surgery. 1985 Oct;98(4):752-9.

PMID:
4049246
41.
42.

Postpneumonectomy pulmonary edema.

Zeldin RA, Normandin D, Landtwing D, Peters RM.

J Thorac Cardiovasc Surg. 1984 Mar;87(3):359-65.

PMID:
6700243
43.

A modified Sugiura procedure.

Ginsberg RJ, Waters PF, Zeldin RA, Spratt EH, Shandling B, Stone RM, Strasberg S.

Ann Thorac Surg. 1982 Sep;34(3):258-64.

PMID:
7051999
44.

Changes in blood P50. Effects on oxygen delivery when arterial hypoxemia is due to shunting.

Rossoff L, Zeldin R, Hew E, Aberman A.

Chest. 1980 Feb;77(2):142-6.

PMID:
7353406

Supplemental Content

Loading ...
Support Center